Workflow
Inventiva(IVA)
icon
Search documents
Inventiva(IVA) - 2021 Q2 - Earnings Call Transcript
2021-09-21 20:20
Inventiva S.A. (NASDAQ:IVA) Q2 2021 Results Conference Call September 21, 2021 8:00 AM ET Â Company Participants Frédéric Cren - Chairman, CEO and Co-Founder Pierre Broqua - CSO and Co-Founder Michael Cooreman - CMO Jean Volatier - CFO Conference Call Participants Lucy Codrington - Jefferies Lenny Van Steenhuyse - KBC Securities Ed Arce - H.C. Wainwright Zegbeh Jallah - Roth Capital Partners Delphine Le Louët - Société Générale Operator Good day and thank you for standing by. Welcome to InventivaÂ's First H ...
Inventiva (IVA) Investor Presentation - Slideshow
2021-06-24 19:52
inventiva | --- | --- | --- | --- | --- | --- | --- | --- | |-----------|------------------------|-------|-------|------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | Developing innovative therapies in | | | | | | NASH and MPS | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Corporate Presentation | | | | | | | | June 2021 | | | | | | | | | | | | | | | | | DISCLAIMER This presentation contains forward-looking sta ...
Inventiva(IVA) - 2020 Q4 - Earnings Call Transcript
2021-03-06 07:16
Inventiva S.A. (OTCPK:IVEVF) Q4 2020 Earnings Conference Call March 5, 2021 8:00 AM ET Company Participants Frédéric Cren - Chairman, Chief Executive Officer and Co-Founder Pierre Broqua - Chief Scientific Officer and Co-Founder Michael Cooreman - Chief Medical Officer Jean Volatier - Chief Financial Officer Conference Call Participants Etzer Darout - Guggenheim Lucy Codrington - Jefferies Lenny Van Steenhuyse - KBC Jean-Jacques Le Fur - Bryan, Garnier Zegbeh Jallah - ROTH Capital Michael Morabito - Chardan ...
Inventiva (IVEVF) Investor Presentation - Slideshow
2021-03-05 22:24
inventiva | --- | --- | --- | --- | --- | --- | --- | --- | |------------|------------------------|-------|-------|------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | Developing innovative therapies in | | | | | | NASH and MPS | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Corporate Presentation | | | | | | | | March 2021 | | | | | | | | | | | | | | | | | | | | | | | | | | DISCLAIMER This presentation contains ...